SCHEMBL6710040

SCHEMBL6710040

CN(C)S(=O)(=O)c1ccc2onc(C(=O)Nc3ccc(C#N)cc3-c3noc(=O)[nH]3)c2c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.38
ALDH1A1 P00352 8/20 0.38
KDM4E B2RXH2 4/20 0.38
SIRT2 Q8IXJ6 2/20 0.33
HIF1A Q16665 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AKR1B1 P15121 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
ALPL P05186 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709039 0.91 ALDH1A1 (0.44) ALDH1A1KDM4ELMNASMN1; SMN2MEN1
SCHEMBL6710165 0.88 ALDH1A1 (0.40) ALDH1A1KDM4EHIF1ALMNAAKR1B1
SCHEMBL6709013 0.88 RXFP1 (0.38) CSF1RALDH1A1KDM4EHIF1ALMNA
SCHEMBL6710163 0.87 HIF1A (0.43) CSF1RSIRT2HIF1ATP53POLB
SCHEMBL6710307 0.86 CSF1R (0.37) CSF1RALDH1A1KDM4ESIRT2HIF1A
SCHEMBL6711761 0.86 HIF1A (0.34) HIF1ATP53POLBMAPT
SCHEMBL6708774 0.85 GPR27 (0.43) HIF1APKMALPL
SCHEMBL6708048 0.85 TNIK (0.36) CSF1RHIF1ATP53POLBMAPT
SCHEMBL6707723 0.84 GRIK1 (0.39) ALDH1A1HIF1ASMN1; SMN2MEN1KMT2A
SCHEMBL6711876 0.84 ALB (0.48) CSF1RALDH1A1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 CSF1R 1430/4885ALDH1A1 123/4885KDM4E 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.